Vaccine potential of a recombinant glutathione S-transferase cloned from Schistosoma haematobium in primates experimentally infected with an homologous challenge

Vaccine

Volumn 17, Issue 4, 1999, Pages 319-326

  Boulanger, Denis ^a   Warter, André ^b   Sellin, Bertrand ^a   Lindner, Véronique ^b   Pierce, Raymond J ^c   Chippaux, Jean Philippe ^a   Capron, André ^c  

^a WHO Collaborating Ctr Contr S   (Niger)

^b Institut de Pathologie Strasbourg   (France)

^c INSERM   (France)

Author keywords

Glutathione S transferase; Primates; Recombinant vaccine; Schistosoma haematobium

Indexed keywords

BCG VACCINE; FREUND ADJUVANT; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; RECOMBINANT VACCINE; SCHISTOSOMA VACCINE;

ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLADDER DISEASE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; IMMUNITY; INTRADERMAL DRUG ADMINISTRATION; MONKEY; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION;

ANIMALS; ANTIBODIES, HELMINTH; CLONING, MOLECULAR; ERYTHROCEBUS PATAS; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; PARASITE EGG COUNT; SCHISTOSOMA HAEMATOBIUM; SEQUENCE HOMOLOGY; VACCINES, SYNTHETIC;

EID: 0345267357     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00202-3     Document Type: Article

References (31)

1. Ismail M., Metwally A., Farghaly A., Bruce J., Tao L.F., Bennett J.L. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Am J Trop Med Hyg. 55:1996;214-218.
2. Fallon P.G., Mubarak J.S., Fookes R.E., Niang M., Butterworth A.E., Sturrock R.F., Doenhoff M.J. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates. Exp Parasitol. 86:1997;29-36.
3. Mitchell G.F. Glutathione S-transferases - Potential components of anti-schistosome vaccines? Parasitol Today. 5:1989;34-37.
4. Brophy P.M., Barrett J. Glutathione transferase in helminths. Parasitology. 100:1990;345-349.
5. Capron A., Dessaint J.P., Capron M., Pierce R.J. Vaccine strategies against schistosomosis. Mem Inst Oswaldo Cruz. 87:1992;19-27.
6. Agnew A., Fulford A.J., Mwanje M.T., Gachuhi K., Gutsmann V., Krijger F.W., Sturrock R.F., Vennervald B.J., Ouma J.H., Butterworth A.E., Deelder A.M. Age-dependent reduction of schistosome fecundity in Schistosoma haematobium but not Schistosoma mansoni infections in humans. Am J Trop Med Hyg. 55:1996;338-343.
7. Trottein F., Godin C., Pierce R.J., Sellin B., Taylor M.G., Gorillot I., Silva M.S., Lecocq J.P., Capron A. Inter-species variation of schistosome 28-kDa glutathione S-transferases. Mol Biochem Parasitol. 54:1992;63-72.
8. Boulanger D., Trottein F., Mauny F., Bremond P., Couret D., Pierce R.J., Kadri S., Godin C., Sellin E., Lecocq J.P., Sellin B., Capron A. Vaccination of goats against the trematode Schistosoma bovis with a recombinant homologous schistosome-derived glutatione S-transferase. Parasite Immunol. 16:1994;399-406.
9. Taylor J.B., Vidal A., Torpier G., Meyer D.J., Roitsch C., Balloul J.M., Southan Ch., Sondermeyer P., Pemble S., Lecocq J.P., Capron A., Ketterer B. The glutathione transferase activity and tissue distribution of a cloned Mr 28 K protective antigen of Schistosoma mansoni. EMBO J. 7:1988;465-472.
10. Sturrock R.F., Butterworth A.E., Houba V. Schistosoma mansoni in the baboon (Papio anubis): parasitological responses of Kenyan baboons to different exposures of a local parasite strain. Parasitology. 73:1976;239-252.
11. Boulanger D., Warter A., Trottein F., Mauny F., Brémond P., Audibert F., Couret D., Kadri S., Godin C., Sellin E., Pierce R.J., Lecocq J.P., Sellin B., Capron A. Vaccination of patas monkeys experimentally infected with Schistosoma haematobium using a recombinant glutathione S-transferase cloned from S. mansoni. Parasite Immunol. 17:1995;361-369.
12. Reid G.D., Sturrock R.F., Harrison R.A., Tarara R.P. Schistosoma haematobium in the baboon (Papio anubis): assessment of protection levels against either a single mass challenge or repeated trickle challenges after vaccination with irradiated schistosomula. J Helminthol. 69:1995;139-147.
13. Inal J., Bickle Q. Sequence and immunogenicity of the 23-kDa transmembrane antigen of Schistosoma haematobium. Mol Biochem Parasitol. 74:1995;217-221.
14. Sulaiman S.M., Hakim M.A., Amin M.A. The location of Schistosoma haematobium (Gezira strain, Sudan) in three experimental animal hosts. Trans R Soc Trop Med Hyg. 76:1982;129.
15. Varley C.A., Dunne D.W., Havercroft J.C. The influence of adjuvant on humoral responses to glutathione-S-transferase fusion proteins. Parasite Immunol. 14:1992;557-562.
16. Auriault C., Wolowczuk I., Gras-Masse H., Marguerite M., Boulanger D., Capron A., Tartar A. Epitopic characterization and vaccinal potential of peptides derived from a major antigen of Schistosoma mansoni (Sm28GST). Pept Res. 4:1991;6-11.
17. Xu C.B., Verwaerde C., Gras-Masse H., Fontaine J., Bossus M., Trottein F., Wolowczuk I., Tartar A., Capron A. Schistosoma mansoni 28-kDa glutathione S-transferase and immunity against parasite fecundity and egg viability. Role of the amino- and carboxyl-terminal domains. J Immunol. 150:1993;940-949.
18. Liu S., Song G., Xu Y., Wen Y., McManus D.P. Immunization of mice with recombinant Sjc26GST induces a pronounced anti-fecundity effect after experimental infection with Chinese Schistosoma japonicum. Vaccine. 13:1995;603-607.
19. Boulanger D., Reid G.D., Sturrock R.F., Wolowczuk I., Balloul J.M., Grezel D., Otieno M.F., Guerret S., Grimaud J.A., Butterworth A.E., Capron A. Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni. Parasite Immunol. 13:1991;473-490.
20. Bushara H.O., Bashir M.E.N., Malik K.H.E., Mukhtar M.M., Trottein F., Capron A., Taylor M.G. Suppression of Schistosoma bovis egg production in cattle by vaccination with either glutathione S-transferase or keyhole limpet haemocyanin. Parasite Immunol. 15:1993;383-390.
21. Liu S., Song G., Xu Y., Yang W., McManus D.P. Anti-fecundity immunity induced in pigs vaccinated with recombinant Schistosoma japonicum 26 kDa glutathione-S-transferase. Parasite Immunol. 17:1995;340-355.
22. Bushara H.O., Omer O.H., Malik K.H., Taylor M.G. The effect of multiple transfers of immune serum on maturing Schistosoma bovis infections in calves. Parasitol Res. 80:1994;198-202.
23. Sexton J.L., Wilce M.C., Colin T., Wijffels G.L., Salvatore L., Feil S., Parker M.W., Spithill T.W., Morrison C.A. Vaccination of sheep against Fasciola hepatica with glutathione S-transferase. Identification and mapping of antibody epitopes on a three-dimensional model of the antigen. J Immunol. 152:1994;1861-1872.
24. Grzych J.M., Grezel D., Xu C.B., Neyrinck J.L., Capron M., Ouma J.H., Butterworth A.E., Capron A. IgA antibodies to a protective antigen in human schistosomosis mansoni. J Immunol. 150:1993;527-535.
25. Convit J., Castellanos P.L., Rondon A., Pinardi M.E., Ulrich M., Castes M., Bloom B., Garcia L. Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis. Lancet. 1(8530):1987;401-405.
26. Convit J., Ulrich M., Aranzazu N., Castellanos P.L., Pinardi M.E., Reyes O. The development of a vaccination model using two microorganisms and its application in leprosy and leishmaniasis. Lepr Rev. 57:1986;263-273.
27. Mastrangelo M.J., Maguire H.C. Jr., Sato T., Nathan F.E., Berd D. Active specific immunization in the treatment of patients with melanoma. Sem Oncol. 23:1996;773-781.
28. Kremer L., Baulard A., Estaquier J., Content J., Capron A., Locht C. Analysis of the Mycobacterium tuberculosis 85A antigen promoter region. J Bacteriol. 177:1995;642-653.
29. Kremer L., Riveau G., Baulard A., Capron A., Locht C. Neutralizing antibody responses elicited in mice immunized with recombinant bacillus Calmette-Guerin producing the Schistosoma mansoni glutathione S-transferase. J Immunol. 156:1996;4309-4317.
30. Guyatt H.L., Evans D. Desirable characteristics of a schistosomosis vaccine: some implications of a cost-effectiveness analysis. Acta Trop. 59:1995;197-209.
31. Woolhouse M.E., Dye C., Etard J.-F., Smith T., Charlwood J.D., Garnett G.P., Hagan P., Hii J.L., Ndhlovu P.D., Quinnell R.J., Watts C.H., Chandiwana S.K., Anderson R.M. Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc Natl Acad Sci USA. 94:1997;338-342.